UA10219A - Method for treatment of pulmonary tuberculosis - Google Patents

Method for treatment of pulmonary tuberculosis

Info

Publication number
UA10219A
UA10219A UA94128208A UA94128208A UA10219A UA 10219 A UA10219 A UA 10219A UA 94128208 A UA94128208 A UA 94128208A UA 94128208 A UA94128208 A UA 94128208A UA 10219 A UA10219 A UA 10219A
Authority
UA
Ukraine
Prior art keywords
preparations
treatment
pulmonary tuberculosis
eneteroparenterally
endolymphatically
Prior art date
Application number
UA94128208A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Ярема Йосипович Пристайко
Ярема Иосифович Пристайко
Юрій Іванович Фещенко
Юрий Иванович Фещенко
Іван Мусійович Сліпуха
Иван Мусиевич Слипуха
Василь Михайлович Мельник
Василий Михайлович Мельник
Микола Степанович Опанасенко
Николай Степанович Опанасенко
Микола Григорович Палівода
Николай Григорьевич Паливода
Original Assignee
Інститут Фтизіатрії І Пульмонології Ім. Ф.Г. Яновського Академії Медичних Наук України
Институт Фтизиатрии И Пульмонологии Им. Ф.Г. Яновского Академии Медицинских Наук Украины
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Інститут Фтизіатрії І Пульмонології Ім. Ф.Г. Яновського Академії Медичних Наук України, Институт Фтизиатрии И Пульмонологии Им. Ф.Г. Яновского Академии Медицинских Наук Украины filed Critical Інститут Фтизіатрії І Пульмонології Ім. Ф.Г. Яновського Академії Медичних Наук України
Priority to UA94128208A priority Critical patent/UA10219A/en
Publication of UA10219A publication Critical patent/UA10219A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to medicine. A method is based on administration to the organism of etiopathogenic preparations of eneteroparenterally and endolymphatically. The preparations are administered endolymphatically, endobronchially and eneteroparenterally simultaneously and ratio of theirs medical treatment duration is 1:1:3 accordingly and the preparations are administered on a background of endobronchial magnetotherapy with the duration, accepted as a 1.
UA94128208A 1994-12-26 1994-12-26 Method for treatment of pulmonary tuberculosis UA10219A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA94128208A UA10219A (en) 1994-12-26 1994-12-26 Method for treatment of pulmonary tuberculosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA94128208A UA10219A (en) 1994-12-26 1994-12-26 Method for treatment of pulmonary tuberculosis

Publications (1)

Publication Number Publication Date
UA10219A true UA10219A (en) 1996-12-25

Family

ID=74552377

Family Applications (1)

Application Number Title Priority Date Filing Date
UA94128208A UA10219A (en) 1994-12-26 1994-12-26 Method for treatment of pulmonary tuberculosis

Country Status (1)

Country Link
UA (1) UA10219A (en)

Similar Documents

Publication Publication Date Title
PL287844A1 (en) Method of obtaining an oraly administered composite medicine for treating interstinal inflamatory diseases
EP1019072A4 (en) Method for assisting in differential diagnosis and treatment of autistic syndromes
CA2189658A1 (en) Controlled-Release Dosage Forms of Azithromycin
GEP20002146B (en) Therapeutic Peptide Derivatives
ES2010561A6 (en) Somatostatin analogue composition and use in treating breast cancer
BG103647A (en) Cisplatina containing microgranules
AU2795395A (en) Novel therapeutic and dietetic uses of a brain phospholipid-based complex
EP0507851A4 (en) Quinolone carboxylic acid--metal ion--acid complexes
CA2154080A1 (en) Novel anticoagulant cofactor activity
AU2807689A (en) Method for the treatment of body tissues and the administration of drugs thereto
UA10219A (en) Method for treatment of pulmonary tuberculosis
AU1200488A (en) Protein c inhibitor (pci) as pharmaceutical and in vitro diagnostic aid, a process for the preparation of a pharmaceutical or diagnostic aid of this type, and an agent containing pci
NZ268039A (en) Use of efaroxan in treating parkinson's disease
AU7373196A (en) Combination of temozolomide and alpha-ifn for the treatment of advanced cancer
Barrett Significance of oral bacteria in acute leukemia.
MD197G2 (en) Preparation and method for hypogalactia treatment
UA19647A (en) Method for treatment of jaw osteomyelitis
AU1162788A (en) Oxime-ethers of 2,6-dioxobicyclo-(3.3.0)octanones for treatment of heart and circulation diseases
Sârbulescu et al. Comparative study of two benzodiazepines (" diazepam" versus" nitrazepam") in the treatment of postneuroleptic tardive dyskinesia.
AU2444695A (en) Use of intravenously administered iron in the therapy of tumoral and infectious diseases
PH30028A (en) Treatment of anxiety in benzodiazepine withdrawn patients
Belousov et al. Experience using cefpirome in pneumonia
UA22223A (en) Method for treatment of vision organ diseases
RU95102346A (en) METHOD FOR TREATING DISCIRCULATORY ENCEPHALOPATHY
UA15070A (en) Method for treatment of malignant tumours in people